Evidence map›Paper›PMID 37166666›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2023

In Vitro Reconstitution of Pseudouridylation Catalyzed by Human Box H/ACA Ribonucleoprotein Particles.

Hironori Adachi, Jonathan L Chen, Qiangzong Yin, Pedro Morais, Yi-Tao Yu

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Hironori AdachiDepartment of Biochemistry and Biophysics, University of Rochester Medical Center, Rochester, NY, USA.
Jonathan L ChenDepartment of Biochemistry and Biophysics, University of Rochester Medical Center, Rochester, NY, USA.
Qiangzong YinDepartment of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA, USA.
Pedro MoraisProQR Therapeutics, Leiden, The Netherlands.
Yi-Tao YuDepartment of Biochemistry and Biophysics, University of Rochester Medical Center, Rochester, NY, USA. YiTao_Yu@URMC.Rochester.edu.
University of Rochester Medical Center · USProQR Therapeutics (Netherlands) · NLUniversity of Massachusetts Chan Medical School · US

Funding

Pseudouridine-mediated branch site recognition/selection during pre-mRNA splicingR01GM138387 · NIGMS · UNIVERSITY OF ROCHESTER · PI YU, YI-TAO · 2020 to 2023
$1.4M
NIGMS NIH HHS R01 GM138387
6 · The paper itself

Abstract

Pseudouridine (Ψ) is the most common chemical modification in RNA. In eukaryotes and archaea, pseudouridine synthases, mainly guided by box H/ACA snoRNAs, convert uridine to Ψ. Ψ stabilizes RNA structure and alters RNA-RNA and RNA-protein interactions, conferring important roles in gene expression. Notably, several Ψ-linked human diseases have been identified over the years. In addition, Ψ has also been extensively used in developing mRNA vaccines. Furthermore, it has been shown that pseudouridylation can be site-specifically directed to modify specific nonsense codons, leading to nonsense suppression. All of these, together with a need to better understand the specific functions of Ψs, have motivated the development of in vitro pseudouridylation assays using purified and reconstituted box H/ACA RNPs. Here, we describe an in vitro system for box H/ACA RNA-guided RNA pseudouridylation using human cell extracts. We show that a half guide RNA (only one hairpin) is just as functionally competent as the full-length guide RNA (two hairpins) in guiding site-specific pseudouridylation in the human cell extracts. This discovery offers the opportunity for direct delivery of a short guide RNA to human cells to promote site-specific nonsense suppression and therefore has potential clinical applications.

Indexed as

PseudouridineRNA, Small NucleolarCatalysisCell ExtractsHumansRibonucleoproteinsCell ExtractsPseudouridineRibonucleoproteinsRNA, Small NucleolarBox H/ACA RNPEpitranscriptomicsIn vitro editing assayPseudouridylationRNA editingRNA modificationTherapeutic oligonucleotides

Identifiers

PMID37166666
OpenAlexW4376133533

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.